Insights

Strategic Partnerships Leverage Bexion's oncology and CNS focus, mid-stage pipeline, and recent MJFF grant to position partnering opportunities with pharma and biotechs seeking collaborations on biologic immunotherapies and CIPN programs.

Clinical momentum Target institutions and CROs involved in solid tumor and CIPN trials, emphasizing BXQ-350's novel S1P modulator mechanism to align with investigators pursuing innovative biologics and expedited development paths.

Funding signals Use the MJFF grant and new leadership additions to underscore financial momentum and credibility when engaging investors, grant partners, and potential co-development deals.

Strategic positioning Highlight opportunities for licensing or collaboration in broader neuropathic pain indications and potential portfolio expansion, aligning with adjacent markets and payer value propositions.

Channel opportunities Capitalize on Bexion’s digital presence and tech stack to run targeted outreach, virtual advisory boards, and co-marketing with contract manufacturers, specialty distributors, and biotech-focused service providers.

Similar companies to Bexion Pharmaceuticals

Bexion Pharmaceuticals Tech Stack

Bexion Pharmaceuticals uses 8 technology products and services including WordPress, Shopify, WooCommerce, and more. Explore Bexion Pharmaceuticals's tech stack below.

Media & News

Bexion Pharmaceuticals's Email Address Formats

Bexion Pharmaceuticals uses at least 4 email formats:
Bexion Pharmaceuticals Email FormatsExamplePercentage
FLast@bexionpharma.comJDoe@bexionpharma.com
87%
First.Last@bexionpharma.comJohn.Doe@bexionpharma.com
7%
F.Last@bexionpharma.comJ.Doe@bexionpharma.com
4%
First@bexionpharma.comJohn@bexionpharma.com
2%

Frequently Asked Questions

What is Bexion Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Bexion Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bexion Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals's official website is bexionpharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Bexion Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of August 2026, Bexion Pharmaceuticals's annual revenue is estimated to be $250M - $500M.

What is Bexion Pharmaceuticals's SIC code and NAICS code?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Bexion Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of August 2026, Bexion Pharmaceuticals has approximately 27 employees across 2 continents, including North America and Asia. Key team members include Vice President Of Chemistry, Manufacturing: G. T., Head Of Distribution: M. S. and Co-Founder: K. X. Explore Bexion Pharmaceuticals's employee directory with LeadIQ.

What industry does Bexion Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Bexion Pharmaceuticals use?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals's tech stack includes WordPress, Shopify, WooCommerce, Microsoft 365, Azure Active Directory, WP Engine, Bootstrap and Microsoft ASP.NET.

What is Bexion Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals's email format typically follows the pattern of FLast@bexionpharma.com. Find more Bexion Pharmaceuticals email formats with LeadIQ.

How much funding has Bexion Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of August 2026, Bexion Pharmaceuticals has raised $18M in funding. The last funding round occurred on Nov 14, 2024 for $1.4M.

When was Bexion Pharmaceuticals founded?

Minus sign iconPlus sign icon
Bexion Pharmaceuticals was founded in 2006.
Bexion Pharmaceuticals logo

Bexion Pharmaceuticals

Biotechnology ResearchKentucky, United States11-50 Employees

Bexion Pharmaceuticals is a small- to mid-sized biotechnology company focused on developing therapies for oncology and the central nervous system. Its lead candidate, BXQ-350, is a novel S1P modulator being developed to address solid tumors and chemotherapy-induced peripheral neuropathy. The company concentrates on biologic therapies and aims to advance its programs through mid-stage clinical development in oncology and CNS indications, with potential expansion to other neuropathic conditions.

Headquartered in Covington, Kentucky, the company operates in the biotechnology research sector. Its leadership team brings extensive biotech experience to guide a pipeline targeting cancer and related neuropathic complications of chemotherapy. A recent development includes participation in ASCO GI 2025, with a poster presentation to share progress from its ongoing studies.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $18M

    Bexion Pharmaceuticals has raised a total of $18M of funding over 3 rounds. Their latest funding round was raised on Nov 14, 2024 in the amount of $1.4M as a Grant.

  • $250M - $500M

    Bexion Pharmaceuticals's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.